Screener
Sutro Biopharma STRO Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's enterprise value?
- Sutro Biopharma (STRO) reported enterprise value of $352.64M in Q1 2026.
- How has Sutro Biopharma's enterprise value changed year-over-year?
- Sutro Biopharma's enterprise value increased by 1262.8% year-over-year, from -$30.33M to $352.64M.
- What is the long-term trend for Sutro Biopharma's enterprise value?
- Over 5 years (2020 to 2025), Sutro Biopharma's enterprise value has grown at a -42.0% compound annual growth rate (CAGR), from $853.62M to $56.11M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Sutro Biopharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude